Delivery Order SPE2DB25D3108-SPE2DB25FPCVE
Award Date 5/6/25
Potential Completion Date 5/28/25
Potential Value $8.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, valued at $17,792.82, is set to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $8.9K delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $8,896.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a targeted cancer therapy medication. This contract, awarded on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a direct fulfillment order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The award carries no set-aside designation and was competitively awarded through open...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Tafinlar 75mg capsules (120 count) with a ceiling value of $35,585.68. This firm fixed-price delivery order, which is expected to be completed by September 26, 2025, represents a non-competitive set-aside award. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) with a contract ceiling value of $8,896.42. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a purchase of pharmaceutical inventory supporting military and veteran...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication, to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its extensive distribution network to rapidly deliver this critical...
- AmerisourceBergen Drug Corp was awarded a $13,836.26 delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of TAFINLAR 50 mg capsules (120-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by October 6, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 count capsules of the oncology medication TAFINLAR 75 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $7,940.73 to supply 120 capsules of TAFINLAR 75 MG CAPSULE. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies to be delivered by December 22, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified. As a leading...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company, to provide 120 capsules of the brand name cancer drug Tafinlar. The delivery order has a ceiling value of $16,278.68 and a period of performance through April 23, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...